HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.
about
Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human DiseasesHLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.HLA-G expression in cancers: roles in immune evasion, metastasis and target for therapyHLA-G expression and role in advanced-stage classical Hodgkin lymphoma.Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment.Hypoxic Modulation of HLA-G Expression through the Metabolic Sensor HIF-1 in Human Cancer CellsHLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer.HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma.HLA-G expression levels influence the tolerogenic activity of human DC-10.Elevated absolute NK cell counts in peripheral blood predict good prognosis in chronic lymphocytic leukemia.HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia.Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells.Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia.
P2860
Q28079536-83482708-037A-4289-ACF2-EBF757FD28B7Q35860201-9D4094EF-CCBA-4D13-B42D-FF7AE2A279E6Q36568297-8ECF2018-C44A-48D3-B1E1-2164AABF8F43Q37067425-75EC8E04-BD5B-4C6B-86E3-0DACE693A44EQ38550810-D405F171-79D2-48A4-B432-9990B35A6392Q38637836-77CACD65-9B7E-46DE-9F83-F3EDA7DFCA63Q38707311-5D183615-90A4-4AD4-A9E2-51DE08AC8F8CQ41050317-239572B1-647B-47DB-AE55-48518E544843Q41465101-B75B9107-F9CE-4070-92F9-CCE7951D9FC9Q48312107-1268F805-3AE1-4B47-AEF1-430128108E7DQ51320808-5F501046-1D0F-4162-A7FE-234470DFA4B9Q52643503-7AB8E684-6DDE-4C56-B59F-6FF3162631BBQ52796916-9D60EDDE-DA49-4353-9B43-6167D2AB3973
P2860
HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
HLA-G is a component of the ch ...... air (rs66554220) polymorphism.
@ast
HLA-G is a component of the ch ...... air (rs66554220) polymorphism.
@en
HLA-G is a component of the ch ...... pact of the HLA-G 14 base pair
@nl
type
label
HLA-G is a component of the ch ...... air (rs66554220) polymorphism.
@ast
HLA-G is a component of the ch ...... air (rs66554220) polymorphism.
@en
HLA-G is a component of the ch ...... pact of the HLA-G 14 base pair
@nl
prefLabel
HLA-G is a component of the ch ...... air (rs66554220) polymorphism.
@ast
HLA-G is a component of the ch ...... air (rs66554220) polymorphism.
@en
HLA-G is a component of the ch ...... pact of the HLA-G 14 base pair
@nl
P2093
P2860
P50
P1433
P1476
HLA-G is a component of the ch ...... air (rs66554220) polymorphism.
@en
P2093
Davide Rossi
Giovanni D'Arena
Lorenzo Moretta
Luca Laurenti
Maria Cristina Mingari
Marina Stignani
Paola Vacca
Roberta Rizzo
Silvia Deaglio
P2860
P304
P356
10.3324/HAEMATOL.2013.095281
P50
P577
2013-12-20T00:00:00Z